Breast cancer is the most common cancer diagnosed and is the second leading cause of
cancer death among women in the US. For breast cancer, early diagnosis and efficient …

Breast cancer cells frequently express tumor-associated antigens that can elicit immune
responses to eradicate cancer. Cancer-testis antigens (CTAs) are a group of tumor …

Simple Summary Triple-negative breast cancer (TNBC) has been associated with worse
prognoses due to the limited treatment options. Thus, there is a need to characterise new …

Tumours frequently activate genes whose expression is otherwise biased to the testis,
collectively known as cancer–testis antigens (CTAs). The extent to which CTA expression …

Breast cancer remains one of the leading causes of death among women across the world.
The last few decades have seen significant reduction in mortality owing to earlier detection …

Background Cancer–testis antigens (CTA) comprise a family of proteins, which are
physiologically expressed in adult human tissues solely in testicular germ cells and …

Cancer–testis (CT) antigens are tumor-associated antigens attracting immunologists for their
possible application in the immunotherapy of cancer. Several clinical trials have assessed …

Abstract Background: Cancer–testis (CT) antigens, frequently expressed in human germline
cells but not in somatic tissues, may become aberrantly reexpressed in different cancer …

Cancer/testis antigens (CTAs) are named based on their expression pattern that is restricted
in a number of normal and abnormal tissues. Tumor cells frequently express antigens whose …

Objective Immunotherapy is an attractive treatment for breast cancer. Cancer-testis antigens
(CTAs) are potential targets for immunotherapy for their restricted expression. Here, we …